tiprankstipranks
Trending News
More News >
Regen Biopharma (RGBP)
OTHER OTC:RGBP
US Market

Regen Biopharma (RGBP) Income Statement

Compare
122 Followers

Regen Biopharma Income Statement

Last quarter (Q3 2025), Regen Biopharma's total revenue was $59.06K, a decrease of 0.00% from the same quarter last year. In Q3, Regen Biopharma's net income was $-167.29K. See Regen Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 236.56K$ 236.56K$ 235.52K$ 171.19K$ 110.00K
Gross Profit
$ 236.56K$ 236.56K$ 185.52K$ 146.19K$ 110.00K
Operating Expenses
$ 653.78K$ 923.51K$ 575.12K$ 346.96K$ 319.32K
Depreciation and Amortization
$ 521.51K$ 1.90M$ 339.61K$ 200.77K$ 209.32K
EBITDA
$ -418.00K$ 3.12M$ 2.99M$ -6.20M$ 4.57M
Operating Income
$ -417.00K$ -687.00K$ -340.00K$ -201.00K$ -209.00K
Other Income/Expenses
$ -251.00K$ 1.84M$ 2.78M$ -6.56M$ 3.62M
Pretax Income
$ -668.00K$ 1.16M$ 2.44M$ -6.76M$ 3.41M
Net Income
$ -668.00K$ 1.02M$ 2.23M$ -6.76M$ 2.73M
Per Share Metrics
Basic EPS
$ -0.16$ 0.14$ 0.36$ -1.69$ 1.90
Diluted EPS
$ -0.16$ 0.14$ 0.36$ -1.69$ 1.90
Weighted Average Shares Outstanding
4.11M 7.07M 3.14M 2.01M 939.90K
Weighted Average Shares Outstanding (Diluted)
4.11M 7.07M 3.14M 2.01M 939.90K
Currency in USD

Regen Biopharma Earnings and Revenue History